191
192 BIBLIOGRAFIA
1. Khoshnood B, Greenlees R, Loane M, Dolk H. Paper 2: EUROCAT public health indicators for congenital anomalies in Europe [Internet]. Vol. 91, Birth Defects Research Part A - Clinical and Molecular Teratology. Inserm; 2011 [cited 2020 Aug 31]. p. S16. Available from: /pmc/articles/PMC3320858/?report=abstract
2. Morris JK, Springett AL, Greenlees R, Loane M, Addor MC, Arriola L, et al. Trends in congenital anomalies in Europe from 1980 to 2012 [Internet]. Vol. 13, PLoS ONE. Public Library of Science; 2018 [cited 2020 Aug 31]. Available from:
/pmc/articles/PMC5886482/?report=abstract
3. Atta CAM, Fiest KM, Frolkis AD, Jette N, Pringsheim T, St Germaine-Smith C, et al.
Global birth prevalence of spina bifida by folic acid fortification status: A systematic review and meta-analysis [Internet]. Vol. 106, American Journal of Public Health.
American Public Health Association Inc.; 2016 [cited 2020 Aug 31]. p. e24–34. Available from: https://pubmed.ncbi.nlm.nih.gov/26562127/
4. Grupo de trabajo de la Sociedad Española de Ginecología y Obstetricia (SEGO). Guía de práctica clínica: Diagnóstico prenatal de los defectos congénitos. Cribado de anomalías cromosómicas. Diagnostico Prenat [Internet]. 2013 Apr 1 [cited 2020 Aug 31];24(2):57–
72. Available from: http://www.elsevier.es/es-revista-diagnostico-prenatal-327-articulo-guia-practica-clinica-diagnostico-prenatal-S2173412712001059
5. Steele M. CHROMOSOME ANALYSIS OF HUMAN AMNIOTIC-FLUID CELLS. Vol. 304, The Lancet. 1974. p. 1210.
6. Jacobson CB, Barter RH. Intrauterine diagnosis and management of genetic defects. Am J Obstet Gynecol [Internet]. 1967 Nov 15 [cited 2016 Jul 19];99(6):796–807. Available from: http://www.ajog.org/article/000293786790395X/fulltext
7. de Klein A, Tibboel D. Genetics. Semin Pediatr Surg [Internet]. 2010 [cited 2020 Aug 31];19(3):234–9. Available from: https://pubmed.ncbi.nlm.nih.gov/20610197/
8. Mansfield ES. Diagnosis of down syndrome and other aneuploidies using quantitative polymerase chain reaction and small tandem repeat polymorphisms. Hum Mol Genet.
1993 Jan;2(1):43–50.
9. Adinolfi M, Pertl B, Sherlock J. Rapid detection of aneuploidies by microsatellite and the quantitative fluorescent polymerase chain reaction. Vol. 17, Prenatal Diagnosis. 1997.
p. 1299–311.
10. Diane Van Opstal1,3, Marjan Boter1,3 D de J. Rapid aneuploidy detection with multiplex ligation-dependent probe amplification: a prospective study of 4000 amniotic fluid samples. Eur J Hum Genet. 2009;17((1):):112–21.
11. Mann K, Fox SP, Abbs SJ, Yau SC, Scriven PN, Docherty Z, et al. Development and implementation of a new rapid aneuploidy diagnostic service within the UK National Health Service and implications for the future of prenatal diagnosis. Lancet.
2001;358(9287):1057–61.
193
12. Grimshaw GM, Szczepura A, Hulten M, MacDonald F, Nevin NC, Sutton F, et al.
Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalities.
Health Technol Assess (Rockv) [Internet]. 2003 [cited 2016 Oct 11];7(10). Available from: http://www.journalslibrary.nihr.ac.uk/hta/volume-7/issue-10
13. Nielsen J. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet. 1991;May;87(1)::81-3.
14. Armengol L, Nevado J, Serra-Juh?? C, Plaja A, Mediano C, Garc??a-Santiago FA, et al.
Clinical utility of chromosomal microarray analysis in invasive prenatal diagnosis. Hum Genet. 2012;131(3):513–23.
15. Wapner RJ, Martin CL, Levy B, Ballif BC, Eng CM, Zachary JM, Savage M, Platt LD, Saltzman D GW, Klugman S, Scholl T, Simpson JL, McCall K, Aggarwal VS, Bunke B, Nahum O, Patel A, Lamb AN, Thom EA B, AL, Ledbetter DH, Shaffer LG JL. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012;Dec
6;367((23):):2175-84.
16. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, et al.
Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.
Science (80- ). 1992;258(5083):818–21.
17. Sagoo GS, Butterworth AS, Sanderson S, Shaw-Smith C, T Higgins JP, Burton H. Array CGH in patients with learning disability (mental retardation) and congenital anomalies:
updated systematic review and meta-analysis of 19 studies and 13,926 subjects. Genet Med 200911(3)139 –146.
18. Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, et al. Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for
Individuals with Developmental Disabilities or Congenital Anomalies. Am J Hum Genet.
2010;86(5):749–64.
19. Hochstenbach R, van Binsbergen E, Engelen J, Nieuwint A, Polstra A, Poddighe P, et al.
Array analysis and karyotyping: Workflow consequences based on a retrospective study of 36,325 patients with idiopathic developmental delay in the Netherlands. Eur J Med Genet. 2009;52(4):161–9.
20. Battaglia A, Doccini V, Bernardini L, Novelli A, Loddo S, Capalbo A, et al. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features. Eur J Paediatr Neurol. 2013;17(6):589–99.
21. South ST, Lee C, Lamb AN, Higgins AW, Kearney HM, Working Group for the American College of Medical Genetics A, et al. ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013. Genet Med. 2013;15(11):901–9.
22. Gross SJ, Bajaj K, Garry D, Klugman S, Karpel BM, Roe AM, et al. Rapid and novel prenatal molecular assay for detecting aneuploidies and microdeletion syndromes.
Prenat Diagn [Internet]. 2011 Mar [cited 2016 Oct 11];31(3):259–66. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/21207408
23. Sahoo T, Cheung SW, Ward P, Darilek S, Patel A, Del Gaudio D, et al. Prenatal diagnosis
194
of chromosomal abnormalities using array-based comparative genomic hybridization.
24. Hillman S, McMullan DJ, Maher ER, Kilby MD. ACOG Committee Opinion No. 446: array comparative genomic hybridization in prenatal diagnosis. Obstet Gynecol [Internet].
2009;114(5):1161–3. Available from: http://doi.wiley.com/10.1111/tog.12007 25. Manning M, Hudgins L, Professional Practice and Guidelines Committee. Array-based
technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med [Internet]. 2010 Nov 18 [cited 2018 Feb 6];12(11):742–5. Available from:
http://www.nature.com/doifinder/10.1097/GIM.0b013e3181f8baad
26. Shinawi M, Cheung SW. The array CGH and its clinical applications. Drug Discov Today.
2008;13(17–18):760–70.
27. Bruce S, Leinonen R, Lindgren CM, Kivinen K, Dahlman-Wright K, Lipsanen-Nyman M, et al. Global analysis of uniparental disomy using high density genotyping arrays. J Med Genet [Internet]. 2005 Nov [cited 2017 Mar 29];42(11):847–51. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/15879501
28. Schroeder C, Sturm M, Dufke A, Mau-Holzmann U, Eggermann T, Poths S, et al.
UPDtool: a tool for detection of iso- and heterodisomy in parent-child trios using SNP microarrays. Bioinformatics [Internet]. 2013 Jun 15 [cited 2017 Mar 29];29(12):1562–4.
Available from: https://academic.oup.com/bioinformatics/article-lookup/doi/10.1093/bioinformatics/btt174
29. Stankiewicz P, Beaudet AL. Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation. Curr Opin Genet Dev. 2007;17(3):182–92.
30. Liang J-S, Shimojima K, Yamamoto T. Application of Array-based Comparative Genome Hybridization in Children with Developmental Delay or Mental Retardation. Pediatr Neonatol. 2008;49(6):213–7.
31. Saldarriaga W, García-Perdomo HA, Arango-Pineda J, Fonseca J. Karyotype versus genomic hybridization for the prenatal diagnosis of chromosomal abnormalities: A metaanalysis. Am J Obstet Gynecol [Internet]. 2015 Mar 1 [cited 2020 Sep
1];212(3):330.e1-330.e10. Available from: http://dx.doi.org/10.1016/j.ajog.2014.10.011 32. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, et al. Detection of
large-scale variation in the human genome. Nat Genet [Internet]. 2004;36(9):949–51.
Available from:
http://www.nature.com/ng/journal/v36/n9/pdf/ng1416.pdf%5Cnhttp://www.nature.c om/doifinder/10.1038/ng1416
33. Mills RE, Walter K, Stewart C, Handsaker RE, Chen K, Alkan C, et al. Mapping copy number variation by population-scale genome sequencing. Nature [Internet]. 2011 Feb 3 [cited 2016 Oct 18];470(7332):59–65. Available from:
http://www.nature.com/doifinder/10.1038/nature09708
34. McCarroll SA, Hadnott TN, Perry GH SP. Common deletion polymorphisms in the human genome. Nat Genet . 2006;Jan;38((1):):86–92.
35. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH AT. Global variation in copy number in
195
the human genome. Nature. 2006;Nov 23(444(7118)):444–54.
36. Horsthemke B, Dittrich B, Buiting K. Imprinting mutations on human chromosome 15 [Internet]. Vol. 10, Human Mutation. Hum Mutat; 1997 [cited 2020 Sep 1]. p. 329–37.
Available from: https://pubmed.ncbi.nlm.nih.gov/9375847/
37. Monk D, Mackay DJG, Eggermann T, Maher ER, Riccio A. Genomic imprinting disorders:
lessons on how genome, epigenome and environment interact [Internet]. Vol. 20, Nature Reviews Genetics. Nature Publishing Group; 2019 [cited 2020 Sep 1]. p. 235–48.
Available from: https://pubmed.ncbi.nlm.nih.gov/30647469/
38. Pinkel D, Albertson DG. COMPARATIVE GENOMIC HYBRIDIZATION. Annu Rev Genomics Hum Genet [Internet]. 2005 Sep [cited 2016 Nov 15];6(1):331–54. Available from:
http://www.annualreviews.org/doi/10.1146/annurev.genom.6.080604.162140 39. Donna G. Albertson DP. Genomic microarrays in human genetic disease and cancer.
Hum Mol Genet [Internet]. 2003;12(145–152). Available from:
https://www.mendeley.com/library/
40. Wolf M, Edgren H, Muggerud A, Kilpinen S, Huusko P, Sørlie T, et al. NMD microarray analysis for rapid genome-wide screen of mutated genes in cancer. Cell Oncol [Internet]. 2005 [cited 2016 Nov 22];27(3):169–73. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/16037637
41. Lisitsyn NA, Lisitsina NM, Dalbagni G, Barker P, Sanchez CA, Gnarra J, et al. Comparative genomic analysis of tumors: detection of DNA losses and amplification. Proc Natl Acad Sci [Internet]. 1995 Jan 3 [cited 2016 Nov 22];92(1):151–5. Available from:
http://www.pnas.org/cgi/content/short/92/1/151
42. Michels E DPK. Detection of DNA copy number alterations in cancer by array comparative genomic hybridization. Genet Med. 2007;Sept;(9(9);):574–84.
43. Leonard H WX. The epidemiology of mental retardation: challenges and opportunities in the new millennium. Ment Retard Dev Disabil Res Rev 2002;8117−34.
44. M. Shevell, MD; S. Ashwal, MD; D. Donley, MD; J. Flint M. Practice parameter:
Evaluation of the child with global developmental delay. Neurology [Internet]. 2006;Feb 11;(60(3):):367-80. Available from: https://www.mendeley.com/library/
45. Moeschler JB, Shevell M, Saul RA, Chen E, Freedenberg DL, Hamid R, et al.
Comprehensive evaluation of the child with intellectual disability or global
developmental delays. Pediatrics [Internet]. 2014 Sep 1 [cited 2020 Sep 2];134(3):e903–
18. Available from: www.pediatrics.org/cgi/doi/10.1542/peds.2014-1839
46. Schalock RL, Luckasson RA, Shogren KA, Borthwick-Duffy S, Bradley V, Buntinx WHE, et al. The renaming of mental retardation: Understanding the change to the term
intellectual disability [Internet]. Vol. 45, Intellectual and Developmental Disabilities.
Intellect Dev Disabil; 2007 [cited 2020 Sep 2]. p. 116–24. Available from:
https://pubmed.ncbi.nlm.nih.gov/17428134/
47. Raynham H, Gibbons R, Flint J, Higgs D. The genetic basis for mental retardation. QJ Med. 1996;89:169–75.
48. John B. Moeschler, MD, Michael Shevell, MD and the C on G. Clinical Genetic
196
Evaluation of the Child With Mental Retardation or Developmental Delays. Pediatrics.
49. C. A. Joyce · N. R. Dennis · S. Cooper · C. E. Browne. Subtelomeric rearrangements:
results from a study of selected and unselected probands with idiopathic mental retardation and control individuals by using high-resolution G-banding and FISH. Hum Genet 109 440–451.
50. Martin CL, Waggoner DJ, Wong A, Uhrig S, Roseberry JA, Hedrick JF, et al.
"Molecular rulers" for calibrating phenotypic effects of telomere imbalance. J Med Genet [Internet]. 2002 Oct [cited 2016 Dec 7];39(10):734–40.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/12362030
51. Ravnan JB. Subtelomere FISH analysis of 11 688 cases: an evaluation of the frequency and pattern of subtelomere rearrangements in individuals with developmental disabilities. J Med Genet [Internet]. 2006 Jun 1 [cited 2016 Nov 29];43(6):478–89.
Available from: http://jmg.bmj.com/cgi/doi/10.1136/jmg.2005.036350 52. Anderlid B-M, Schoumans J, Annerén G, Sahlén S, Kyllerman M, Vujic M, et al.
Subtelomeric rearrangements detected in patients with idiopathic mental retardation.
Am J Med Genet [Internet]. 2002 Feb 1 [cited 2016 Dec 7];107(4):275–84. Available from: http://doi.wiley.com/10.1002/ajmg.10029
53. Knight SJ, Regan R, Nicod A, Horsley SW, Kearney L, Homfray T, et al. Subtle
chromosomal rearrangements in children with unexplained mental retardation. Lancet.
1999;354(9191):1676–81.
54. Veltman JA, Schoenmakers EFPM, Eussen BH, Janssen I, Merkx G, van Cleef B, et al.
High-throughput analysis of subtelomeric chromosome rearrangements by use of array-based comparative genomic hybridization. Am J Hum Genet [Internet]. 2002 May [cited 2016 Nov 29];70(5):1269–76. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/11951177
55. Vissers LELM, De Vries BBA, Osoegawa K, Janssen IM, Feuth T, Choy CO, et al. Array-Based Comparative Genomic Hybridization for the Genomewide Detection of Submicroscopic Chromosomal Abnormalities. Am J Hum Genet. 2003;73:1261–70.
56. Shaw-Smith C, Redon R, Rickman L, Rio M, Willatt L, Fiegler H, et al. Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features. J Med Genet. 2004;41:241–8.
57. Guitart-Feliubadaló M, Brunet-Vega A, Villatoro-Gómez S, Baena-Díez N, Gabau-Vila E.
[Chromosomal causes that produce mental retardation: chromosome disorders that can be diagnosed in the patient]. Rev Neurol [Internet]. 2006 Jan 7 [cited 2018 Mar 6];42 Suppl 1:S21-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16506128 58. Thuresson A-C, Bondeson M-L, Edeby C, Ellis P, Langford C, Dumanski JP, et al.
Whole-genome array-CGH for detection of submicroscopic chromosomal imbalances in children with mental retardation. Cytogenet Genome Res [Internet]. 2007 [cited 2016 Dec 13];118:1–7. Available from: www.karger.com
59. Schoumans J, Ruivenkamp C, Holmberg E, Kyllerman M, Anderlid B, Nordenskjöld M.
Detection of chromosomal imbalances in children with idiopathic mental retardation by
197
array based comparative genomic hybridisation (array-CGH). J Med Genet.
2005;42:699–705.
60. Vasudevan P, Suri M. A clinical approach to developmental delay and intellectual disability. Clin Med J R Coll Physicians London [Internet]. 2017 Dec 1 [cited 2020 Sep 2];17(6):558–61. Available from: /pmc/articles/PMC6297696/?report=abstract 61. De Gregori M, Ciccone R, Magini P, Pramparo T, Gimelli S, Messa J, et al. Cryptic
deletions are a common finding in "balanced" reciprocal and complex chromosome rearrangements: a study of 59 patients. J Med Genet [Internet]. 2007 Dec [cited 2017 Feb 7];44(12):750–62. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/17766364
62. Resta N, Memo L. Chromosomal microarray (CMA) analysis in infants with congenital anomalies: when is it really helpful? J Matern Neonatal Med [Internet]. 2012 Oct 8 [cited 2016 Dec 13];25(sup4):116–8. Available from:
http://www.tandfonline.com/doi/full/10.3109/14767058.2012.715004
63. Scott SA, Cohen N, Brandt T, Toruner G, Desnick RJ, Edelmann L. Detection of low-level mosaicism and placental mosaicism by oligonucleotide array comparative genomic hybridization.
64. Conlin LK, Thiel BD, Bonnemann CG, Medne L, Ernst LM, Zackai EH, et al. Mechanisms of mosaicism, chimerism and uniparental disomy identified by single nucleotide
polymorphism array analysis. Hum Mol Genet [Internet]. 2010 Apr 1 [cited 2017 Mar 29];19(7):1263–75. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20053666 65. First MB. Paradigm Shifts and the Development of the Diagnostic and Statistical. Can J
Psychiatry. 2010;55(11).
66. Muhle R, Trentacoste S V., Rapin I. The Genetics of Autism. Pediatrics. 2004;113(5).
67. Kogan MD, Blumberg SJ, Schieve LA, Boyle CA, Perrin JM, Ghandour RM, et al.
Prevalence of Parent-Reported Diagnosis of Autism Spectrum Disorder Among Children in the US, 2007. Pediatrics. 2009;124(5).
68. Kim YS, Leventhal BL, Koh Y-J, Fombonne E, Laska E, Lim E-C, et al. Prevalence of Autism Spectrum Disorders in a Total Population Sample. Am J Psychiatry [Internet]. 2011 Sep [cited 2016 Dec 20];168(9):904–12. Available from:
http://psychiatryonline.org/doi/abs/10.1176/appi.ajp.2011.10101532
69. Baxter AJ, Brugha TS, Erskine HE, Scheurer RW, Vos T, Scott JG. The epidemiology and global burden of autism spectrum disorders. Psychol Med [Internet]. 2015 Feb 11 [cited 2016 Dec 20];45(3):601–13. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/25108395
70. Posserud M, Lundervold AJ, Lie SA, Gillberg C. The prevalence of autism spectrum disorders: impact of diagnostic instrument and non-response bias. Soc Psychiatry Psychiatr Epidemiol [Internet]. 2010 Mar 24 [cited 2016 Dec 20];45(3):319–27.
Available from: http://link.springer.com/10.1007/s00127-009-0087-4
71. Baird G, Simonoff E, Pickles A, Chandler S, Loucas T, Meldrum D, et al. Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames:
the Special Needs and Autism Project (SNAP). Lancet. 2006;368(9531):210–5.
198
72. Matson JL, Kozlowski AM. The increasing prevalence of autism spectrum disorders. Res Autism Spectr Disord. 5:418–25.
73. Fombonne E. Epidemiology of Autistic Disorder and Other Pervasive Developmental Disorders. J Clin Psychiatry. 2005;66(suppl 10):3–8.
74. Chakrabarti S, Fombonne MRCPE, Psych FRC. Pervasive Developmental Disorders in Preschool Children: Confirmation of High Prevalence. Am J Psychiatry [Internet]. 2005 [cited 2016 Dec 20];1626. Available from: http://ajp.psychiatryonline.org
75. Wing L, Potter D. The epidemiology of autistic spectrum disorders: is the prevalence rising? Ment Retard Dev Disabil Res Rev [Internet]. 2002 [cited 2017 Jan 10];8(3):151–
61. Available from: http://doi.wiley.com/10.1002/mrdd.10029
76. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4 ed, text revision (DSM-IV-TR). Washington DC: American Psychiatric Publishing; 2000.
77. Williams JG. Systematic review of prevalence studies of autism spectrum disorders.
Arch Dis Child [Internet]. 2005 May 10 [cited 2017 Jan 10];91(1):8–15. Available from:
http://adc.bmj.com/cgi/doi/10.1136/adc.2004.062083
78. WAZANA A, BRESNAHAN M, KLINE J. The Autism Epidemic: Fact or Artifact? J Am Acad Child Adolesc Psychiatry. 2007;46(6):721–30.
79. Grant R, Nozyce M. Proposed Changes to the American Psychiatric Association Diagnostic Criteria for Autism Spectrum Disorder: Implications for Young Children and Their Families. Matern Child Health J [Internet]. 2013 May 2 [cited 2017 Jan
10];17(4):586–92. Available from: http://link.springer.com/10.1007/s10995-013-1250-9 80. Blaxill MF. What’s going on? The question of time trends in autism. Public Health Rep
[Internet]. 2004 [cited 2017 Jan 10];119(6):536–51. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/15504445
81. Sandin S, Lichtenstein P, Kuja-Halkola R, Larsson H, Hultman CM, Reichenberg A, et al.
The Familial Risk of Autism. JAMA [Internet]. 2014 May 7 [cited 2017 Jan 10];311(17):1770. Available from:
http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2014.4144
82. Bailey A1, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E RM. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med [0033-2917]
Bailey, A Any1995 vol25 núm1 Pàg63 -77 [Internet]. [cited 2017 Jan 24]; Available from:
http://sfx.cbuc.cat/uab?sid=Entrez:PubMed&id=pmid:7792363#.WIb1TlXhDIU 83. C.P. Lawler, L.A. Croen, J.K. Grether, J. Van de Water Identifying environmental
contributions to autism: provocative clues and false leads Ment Retard Dev Disabil Res Rev, 10 (4) (2004), pp. 292–302.
84. Trasande L. Environmental Contributors to Autism: The Pediatrician׳s Role. Vol. 44, Current Problems in Pediatric and Adolescent Health Care. 2014.
85. Surén P, Roth C, Bresnahan M, Haugen M, Hornig M, Hirtz D, et al. Association between maternal use of folic acid supplements and risk of autism spectrum disorders in
children. JAMA [Internet]. 2013 Feb 13 [cited 2017 Mar 30];309(6):570–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23403681